BREAST CANCER METASTATIC
Clinical trials for BREAST CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER METASTATIC trials appear
Sign up with your email to follow new studies for BREAST CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New breast cancer drug shows promise in slowing tumor growth
Disease control TerminatedThis study tested a new drug called amcenestrant against standard hormone therapies for people with a common type of advanced breast cancer (ER+/HER2-). The goal was to see if the new drug could delay cancer growth better than existing options. About 367 adults who had already tr…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Experimental cancer drug shows promise but study halted early
Disease control TerminatedThis study tested a drug called tusamitamab ravtansine in people with advanced breast or pancreatic cancer that has spread and has a specific marker (CEACAM5). The goal was to see if the drug could shrink tumors, either alone or with another chemotherapy. The study was stopped ea…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 11, 2026 20:37 UTC